Global Infectious Disease Research Solutions Market Growth (Status and Outlook) 2025-2031

The global Infectious Disease Research Solutions market size is predicted to grow from US$ 2727 million in 2025 to US$ 3902 million in 2031; it is expected to grow at a CAGR of 6.2% from 2025 to 2031.

Infectious Disease Research Solutions refer to the range of tools, technologies, methodologies, and services designed to support the study, detection, treatment, and prevention of infectious diseases. These solutions are developed and employed by researchers, healthcare professionals, and pharmaceutical companies to better understand pathogens (bacteria, viruses, fungi, etc.), how they spread, and how to combat them effectively.

United States market for Infectious Disease Research Solutions is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Infectious Disease Research Solutions is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Infectious Disease Research Solutions is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Infectious Disease Research Solutions players cover Thermo Fisher Scientific, Revvity, Sino Biological, Roche, Agilent, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Infectious Disease Research Solutions Industry Forecast” looks at past sales and reviews total world Infectious Disease Research Solutions sales in 2024, providing a comprehensive analysis by region and market sector of projected Infectious Disease Research Solutions sales for 2025 through 2031. With Infectious Disease Research Solutions sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infectious Disease Research Solutions industry.

This Insight Report provides a comprehensive analysis of the global Infectious Disease Research Solutions landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Infectious Disease Research Solutions portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infectious Disease Research Solutions market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Disease Research Solutions and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Disease Research Solutions.

This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Disease Research Solutions market by product type, application, key players and key regions and countries.

Segmentation by Type:
Molecular Diagnostics
Vaccine Development
Therapeutic Options
Drug Discovery and Screening
Epidemiology Tools and Data Analysis

Segmentation by Application:
Viral Infection
Bacterial Infection

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Revvity
Sino Biological
Roche
Agilent
IQVIA
Boca Bio
Sartorius
Charles River
Microbix Biosystems
Quidel Ortho
Bio-Rad Laboratories
Abbott Laboratories

Please note: The report will take approximately 2 business days to prepare and deliver.